For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow Gems #196
Wednesday 21 June 2023, 12:43 AM

[Image: Lucy Wolski on Unsplash]
“PPIs not helpful for infants, and evidence of harm”
In the 15 May Tools for Practice, evidence indicates that proton pump inhibitor use in babies does not improve crying, fussiness, irritability or regu
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
tinyurl.com/ToolsForPractice340 (Tools for Practice #340, 15 May 2023).